Cardio Diagnostics Holdings is trading at $2.02 (+5.60%) in pre-market, with no new company-specific announcement or major catalyst identified for August 26, 2026.
- The latest notable company news was the August 18 launch of an in-house CLIA-certified laboratory, which appears stale for this move.
- The S&P 500 is up 0.04% and Nasdaq is down 0.10%, offering no strong directional explanation.
- Low-liquidity trading or reversal buying may be factors, but causation remains unconfirmed.